ReShape Lifesciences is a weight-loss solutions company, providing a portfolio of products and services that manage and treat obesity and associated metabolic disease. Co.'s primary operations are in the following geographical areas: U.S., Australia and certain European and Middle Eastern countries. Co.'s portfolio includes the Lap-Band Adjustable Gastric Banding System, the reshapecare virtual health coaching program, the ReShape Marketplace, the Obalon Balloon System, the ReShape Vest, an investigational device to help treat more patients with obesity, and the Diabetes Bloc-Stim Neuromodulation device, a technology under development as a new treatment for type 2 diabetes mellitus. We show 15 historical shares outstanding datapoints in our coverage of RSLS's shares outstanding history.
Understanding the changing numbers of RSLS shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like RSLS versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching RSLS by allowing them to research RSLS shares outstanding history
as well as any other stock in our coverage universe. |
Free RSLS Email Alerts:
Video: Shares Outstanding Importance
